CASC3 and neoplasm: In conclusion, this study reported that BTZ@HMSNs showed improved tumor-suppressing effect on SNK-1 cells compared to free BTZ, which might be attributable to the multiple attractive properties, including highly-hydrophilic nature, excellent biocompatibility and sustained drug releasing.